These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 36519327)
1. Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19. Busch MH; Timmermans SAMEG; Van Kuijk SMJ; Aendekerk JP; Ysermans R; Van Doorn DPC; Potjewijd J; Van de Poll MCG; Van der Horst ICC; Damoiseaux JGMC; Spronk HMH; Cate HT; Reutelingsperger CP; Nagy M; Van Paassen P Haematologica; 2023 May; 108(5):1417-1422. PubMed ID: 36519327 [No Abstract] [Full Text] [Related]
2. The effect of von Willebrand factor on activation of factor VIII by factor Xa. Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896 [TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. Hill-Eubanks DC; Lollar P J Biol Chem; 1990 Oct; 265(29):17854-8. PubMed ID: 2120219 [TBL] [Abstract][Full Text] [Related]
4. Reactions of thrombin with human factor VIII/von Willebrande factor protein. Switzer ME; McKee PA J Biol Chem; 1980 Nov; 255(22):10606-11. PubMed ID: 6776120 [No Abstract] [Full Text] [Related]
6. The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy. Delbrück C; Miesbach W Acta Haematol; 2019; 142(2):71-78. PubMed ID: 31085919 [TBL] [Abstract][Full Text] [Related]
7. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor. Switzer ME; Gordon HJ; McKee PA Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490 [TBL] [Abstract][Full Text] [Related]
8. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Hill-Eubanks DC; Parker CG; Lollar P Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6508-12. PubMed ID: 2505252 [TBL] [Abstract][Full Text] [Related]
9. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance. Terraube V; O'Donnell JS; Jenkins PV Haemophilia; 2010 Jan; 16(1):3-13. PubMed ID: 19473409 [TBL] [Abstract][Full Text] [Related]
10. Factor VIII-mediated global hemostasis in the absence of von Willebrand factor. Takeyama M; Kasuda S; Sakurai Y; Shima M; Takeda T; Omura S; Naka H; Yoshioka A Int J Hematol; 2007 Jun; 85(5):397-402. PubMed ID: 17562614 [TBL] [Abstract][Full Text] [Related]
11. Interaction between VWF and FVIII in treating VWD. Miesbach W; Berntorp E Eur J Haematol; 2015 Nov; 95(5):449-54. PubMed ID: 25605439 [TBL] [Abstract][Full Text] [Related]
12. Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (Von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF. Stibbe J Thromb Res; 1977 Jan; 10(1):163-8. PubMed ID: 300513 [No Abstract] [Full Text] [Related]
13. Physiological Roles of the von Willebrand Factor-Factor VIII Interaction. Kiouptsi K; Reinhardt C Subcell Biochem; 2020; 94():437-464. PubMed ID: 32189311 [TBL] [Abstract][Full Text] [Related]
14. Treatment of von Willebrand disease. Mannucci PM Haemophilia; 1998 Jul; 4(4):661-4. PubMed ID: 9873811 [TBL] [Abstract][Full Text] [Related]
15. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Mazurier C; Meyer D Thromb Haemost; 1996 Aug; 76(2):270-4. PubMed ID: 8865544 [No Abstract] [Full Text] [Related]
16. Review of von Willebrand Disease and Acquired von Willebrand Syndrome for Patients Undergoing Cardiac Surgery. Berger J; Schwartz J; Ramachandran S; Leff JD J Cardiothorac Vasc Anesth; 2019 Dec; 33(12):3446-3457. PubMed ID: 31570241 [No Abstract] [Full Text] [Related]
17. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor. Yada K; Nogami K; Shima M Br J Haematol; 2013 Oct; 163(1):104-11. PubMed ID: 23889549 [TBL] [Abstract][Full Text] [Related]
18. Elevated plasma factor VIII enhances venous thrombus formation in rabbits: contribution of factor XI, von Willebrand factor and tissue factor. Sugita C; Yamashita A; Matsuura Y; Iwakiri T; Okuyama N; Matsuda S; Matsumoto T; Inoue O; Harada A; Kitazawa T; Hattori K; Shima M; Asada Y Thromb Haemost; 2013 Jul; 110(1):62-75. PubMed ID: 23636277 [TBL] [Abstract][Full Text] [Related]
19. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII. Rick ME; Krizek DM Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631 [TBL] [Abstract][Full Text] [Related]
20. On the discrepant post-DDAVP increase of FVIII:C and von Willebrand factor in some patients with severe von Willebrand's disease. Casonato A; Pontara E; Bertomoro A; Zucchetto A; Zerbinati A; Girolami A Br J Haematol; 1995 Oct; 91(2):512-3. PubMed ID: 8547104 [No Abstract] [Full Text] [Related] [Next] [New Search]